
On 9 August 2023, Astellas Pharma announced its plans to open what it has described as a “state-of-the-art life sciences …
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board

